mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: consequences of expression of HPV16 E4 and E5.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 24898764)

Published in J Med Virol on June 05, 2014

Authors

Dean Bryant1, Tiffany Onions, Rachel Raybould, Áine Flynn, Amanda Tristram, Sian Meyrick, Peter Giles, Kevin Ashelford, Samantha Hibbitts, Alison Fiander, Ned Powell

Author Affiliations

1: HPV Research Group, School of Medicine, Cardiff University, Wales, United Kingdom.

Articles by these authors

Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry (2005) 2.58

Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry (2006) 2.16

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol (2004) 2.15

Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol (2008) 1.93

Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet (2002) 1.77

Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res (2004) 1.51

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer (2012) 1.48

Transcriptomics and in vivo tests reveal novel mechanisms underlying endocrine disruption in an ecological sentinel, Nucella lapillus. Mol Ecol (2012) 1.46

Pyrosequencing of Mytilus galloprovincialis cDNAs: tissue-specific expression patterns. PLoS One (2010) 1.41

Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry (2006) 1.19

Epidemiology of pelvic organ prolapse in rural Gambia, West Africa. BJOG (2002) 1.15

Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem (2009) 1.15

Identification of human papillomavirus type 58 lineages and the distribution worldwide. J Infect Dis (2011) 1.13

Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. Int J Cancer (2013) 1.05

Recovery of human papillomavirus nucleic acids from liquid-based cytology media. J Virol Methods (2006) 1.05

From small hosts come big viruses: the complete genome of a second Ostreococcus tauri virus, OtV-1. Environ Microbiol (2009) 1.03

P2RX7: A bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet (2009) 1.00

The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol (2006) 1.00

Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer (2013) 0.92

Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection. J Clin Virol (2011) 0.92

Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int J Cancer (2012) 0.91

Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Hum Mol Genet (2012) 0.90

Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia. Gynecol Oncol (2005) 0.89

Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. Int Immunol (2004) 0.89

Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health (2013) 0.89

Characterising women with obstetric fistula and urogenital tract injuries in Tanzania. Int Urogynecol J (2013) 0.87

Psychosocial impact of obstetric fistula in women presenting for surgical care in Tanzania. Int Urogynecol J (2012) 0.87

An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making. Gynecol Oncol (2004) 0.85

The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. Int J Cancer (2009) 0.84

Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database Syst Rev (2013) 0.82

Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy. Cancer Immunol Immunother (2013) 0.81

Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK). J Clin Virol (2013) 0.80

Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray. J Med Virol (2011) 0.79

Single negative colposcopy: is it enough to rule out high-grade disease? J Med Screen (2011) 0.77

Multicentric human papillomavirus-associated head and neck squamous cell carcinoma. Head Neck (2014) 0.77

Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland. Purinergic Signal (2009) 0.75

Vaccination against cervical cancer. Hosp Med (2004) 0.75